KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data shows that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. According to public health figures published by the Ministry of Public Health and Prevention, the country has recorded 5,713 confirmed cases and 2,744 deaths. The current case fatality rate among confirmed patients is approximately 48%.
This public health emergency has prompted support from international health agencies, including the World Health Organization, to assist local medical teams with logistics, laboratory testing, and vaccine distribution. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers gather observational data on its effectiveness against the circulating viral strain. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination efforts around identified infection clusters to break transmission chains.
Health Ministry Focuses on Allocating Ervebo Doses to Medical Staff in Kisangani
Operational challenges in logistics are evident due to complex regional infrastructure, ongoing security issues, and high mobility of populations across border districts. Cold-chain networks have been established in Kisangani to ensure vaccines are stored at the ultra-low temperatures required before transportation to remote health zones. DR Congo has initiated Ebola vaccination efforts while civil defense and community health workers conduct outreach to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working alongside local response teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials highlight that early detection, combined with isolation protocols and supportive treatment, remains critical for improving patient survival rates. Additional vaccine shipments are planned as distribution expands to secondary health districts across the region.
Health Authorities Implement Rigorous Infection Control Measures at Treatment Facilities
National teams continue expanding contact-tracing efforts throughout urban and rural areas in the eastern region. Local health clinics are receiving personal protective equipment, diagnostic reagents, and therapeutic supplies to enhance their readiness. The government ministries have reaffirmed that comprehensive public health strategies will stay in place until data shows a consistent decline in viral transmission across all affected provinces.
The government urges communities to fully cooperate with mobile vaccination units and follow established health guidelines. It is expected that increasing immunization among high-risk populations will help stabilize infection rates in the coming weeks. Surveillance networks will continue heightened monitoring at transportation hubs and border crossings to prevent further spread geographically.